Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062790
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2003-06-16
Brief Title:
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone DHT Levels
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Effects of Dutasteride on Intraprostatic Dihydrotestosterone DHT Levels
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to determine how much certain hormone levels in the prostate decrease when a patient takes dutasteride 05mg daily for 3 months prior to TURP Male patients at least 50 years old willing to take either dutasteride or a placebo dummy pill once daily by mouth for 3 months prior to having a surgery to reduce the size of their prostate During the surgery very small pieces of the prostate that are removed will be tested to see how much dihydrotestosterone and testosterone male hormones are in the tissue
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None